Castorino, Kristin
Osumili, Beatrice
Lakiang, Theophilus
Banerjee, Kushal Kumar
Goldyn, Andrea
Piras de Oliveira, Carolina
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 7 November 2023
Accepted: 1 February 2024
First Online: 18 March 2024
Declarations
:
: Beatrice Osumili, Kushal Kumar Banerjee, Andrea Goldyn, and Carolina Piras De Oliveira are full-time employees and shareholders of Eli Lilly and Company. Theophilus Lakiang was an employee of Eli Lilly and Company at the time this research was conducted and is currently an employee of GE Healthcare. Kristin Castorino receives research support provided to her institution from Dexcom, Abbott, Medtronic, Novonordisk, Ely Lilly, and Insulet and consulting fees from Dexcom. Theophilus Lakiang: Author affiliation has changed since the time this research was conducted. Assigned affiliation is the institution of employment at the time this research was conducted.
: This article is based on previously conducted studies and does not contain any studies with human participants or animals.